This invention relates to: (a) compounds of formula I (with R1 to R5 and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-β-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of such compounds, salts or solvates in therapy; (d) therapeutic methods of treatment using such compounds, salts or solvates; and (e) processes and intermediates useful for the synthesis of such compounds.
本发明涉及:(a) 公式I中的化合物(其中R1至R5和A如本文所定义)及其药用可接受的盐或溶剂,这些化合物可用作
多巴胺-β-羟化酶
抑制剂;(b) 包括这些化合物、盐或溶剂的药物组合物;(c) 使用这些化合物、盐或溶剂进行治疗;(d) 使用这些化合物、盐或溶剂进行治疗的治疗方法;以及(e) 用于合成这些化合物的过程和
中间体。